DK104630C - Fremgangsmåde til fremstilling af substituerede, sekundære eller tertiære aralkylaminoalkoholestere af subtitueret benzoesyre eller salte deraf. - Google Patents

Fremgangsmåde til fremstilling af substituerede, sekundære eller tertiære aralkylaminoalkoholestere af subtitueret benzoesyre eller salte deraf.

Info

Publication number
DK104630C
DK104630C DK260361AA DK260361A DK104630C DK 104630 C DK104630 C DK 104630C DK 260361A A DK260361A A DK 260361AA DK 260361 A DK260361 A DK 260361A DK 104630 C DK104630 C DK 104630C
Authority
DK
Denmark
Prior art keywords
substituted
aralkylamino
tertiary
salts
preparation
Prior art date
Application number
DK260361AA
Other languages
Danish (da)
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Application granted granted Critical
Publication of DK104630C publication Critical patent/DK104630C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK260361AA 1957-11-23 1958-11-20 Fremgangsmåde til fremstilling af substituerede, sekundære eller tertiære aralkylaminoalkoholestere af subtitueret benzoesyre eller salte deraf. DK104630C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL222701 1957-11-23

Publications (1)

Publication Number Publication Date
DK104630C true DK104630C (da) 1966-06-13

Family

ID=19751044

Family Applications (1)

Application Number Title Priority Date Filing Date
DK260361AA DK104630C (da) 1957-11-23 1958-11-20 Fremgangsmåde til fremstilling af substituerede, sekundære eller tertiære aralkylaminoalkoholestere af subtitueret benzoesyre eller salte deraf.

Country Status (7)

Country Link
US (1) US3265577A (forum.php)
CH (3) CH386447A (forum.php)
DK (1) DK104630C (forum.php)
FR (1) FR1219254A (forum.php)
GB (1) GB914783A (forum.php)
NL (1) NL112650C (forum.php)
OA (1) OA00968A (forum.php)

Also Published As

Publication number Publication date
NL112650C (forum.php)
OA00968A (fr) 1968-08-07
CH415663A (de) 1966-06-30
US3265577A (en) 1966-08-09
GB914783A (en) 1963-01-02
CH386447A (de) 1965-01-15
CH398629A (de) 1966-03-15
FR1219254A (fr) 1960-05-17

Similar Documents

Publication Publication Date Title
DK118404B (da) Fremgangsmåde til fremstilling af phenthiazinforbindelser eller syreadditionssalte heraf.
DK104415C (da) Fremgangsmåde til fremstilling af substituerede sekundære eller tertiære aralkyl-amino-alkohol-estere af substitueret benzoesyre eller syreadditionssalte deraf.
DK104630C (da) Fremgangsmåde til fremstilling af substituerede, sekundære eller tertiære aralkylaminoalkoholestere af subtitueret benzoesyre eller salte deraf.
DK101797C (da) Fremgangsmåde til fremstilling af substituerede, sekundære eller tertiære aralkylaminoalkoholestere af subtitueret benzoesyre eller salte deraf.
DK102408C (da) Fremgangsmåde til fremstilling af substituerede, sekundære eller tertiære aralkylaminoalkoholestere af substitueret benzoesyre eller salte deraf.
DK95743C (da) Fremgangsmåde til fremstilling af substituerede sekundære eller tertiære aralkylamino-alkoholestere af substitueret benzoesyre eller syreadditionssalte deraf.
DK95947C (da) Fremgangsmåde til fremstilling af substituerede sekundære eller tertiære aralkylamino-alkoholestere af substitueret benzoesyre eller syreadditionssalte deraf.
DK97293C (da) Fremgangsmåde til fremstilling af substituerede sekundære eller tertiære aralkylamino-alkoholestere af substitueret benzoesyre.
DK88840C (da) Fremgangsmåde til fremstilling af estere af 2-piperidylphenylmethanol eller syreadditionssalte deraf.
DK88781C (da) Fremgangsmåde til fremstilling af estere af 2-piperidylphenylmethanol eller syreadditionssalte deraf.
DK88001C (da) Fremgangsmåde til fremstilling af estere af 2-piperidylphenylmethanol eller syreadditionssalte deraf.
DK96414C (da) Fremgangsmåde til fremstilling af morfolinacylanilidforbindelser eller syreadditionssalte deraf.
DK90707C (da) Fremgangsmåde til fremstilling af piperidinforbindelser eller syreadditionssalte deraf.
DK90438C (da) Fremgangsmåde til fremstilling af piperidinforbindelser eller syreadditionssalte deraf.
DK90437C (da) Fremgangsmåde til fremstilling af piperidinforbindelser eller syreadditionssalte deraf.
DK96115C (da) Fremgangsmåde til fremstilling af quinolinforbindelser eller syreadditionssalte deraf.
DK96114C (da) Fremgangsmåde til fremstilling af quinolinforbindelser eller syreadditionssalte deraf.
DK91219C (da) Fremgangsmåde til fremstilling af 1-phenylcyclohexylamin eller syreadditionssalte heraf.
DK93399C (da) Fremgangsmåde til fremstilling af 1-phenylcyclohexylamin eller syreadditionssalte heraf.
DK108501C (da) Fremgangsmåde til fremstilling af thiaxanthen-forbindelser eller syreadditionssalte heraf.
DK94991C (da) Fremgangsmåde til fremstilling af α-chlor-β-aminocarboxylsyreforbindelser eller syreadditionssalte deraf.
DK92449C (da) Fremgangsmåde til fremstilling af 1-phenylcyclohexylaminforbindelser eller syreadditionssalte heraf.
DK90436C (da) Fremgangsmåde til fremstilling af piperindinforbindelser eller syreadditionssalte deraf.
DK89442C (da) Fremgangsmåde til fremstilling af phenylglycinestere eller syreadditionssalte heraf.
DK91073C (da) Fremgangsmåde til fremstilling af cyclohexylaminforbindelser eller syreadditionssalte heraf.